Increased risk of major adverse cardiac events following the onset of acute exacerbations of COPD

Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial

(2018) Ken M. Kunisaki et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Association of Cardiovascular Risk With Inhaled Long-Acting Bronchodilators in Patients With Chronic Obstructive Pulmonary Disease

(2018) Meng-Ting Wang et al.   JAMA Internal Medicine

Risk of cardiovascular events, arrhythmia and all-cause mortality associated with clarithromycin versus alternative antibiotics prescribed for respiratory tract infections: a retrospective cohort study

(2017) Ellen Berni et al.   BMJ Open

Stability of the frequent COPD exacerbator in the general population: A Danish nationwide register-based study

(2017) Mette Reilev et al.   npj Primary Care Respiratory Medicine

Cardiovascular outcomes associated with use of clarithromycin: population based study

(2016) Angel Y S Wong et al.   BMJ-British Medical Journal

Cardiovascular outcomes associated with use of clarithromycin: population based study

(2016) Angel Y S Wong et al.   BMJ-British Medical Journal

Cardiac dysfunction during exacerbations of chronic obstructive pulmonary disease

(2016) Martin I MacDonald et al.   Lancet Respiratory Medicine

Medically treated exacerbations in COPD by GOLD 1-4: A valid, robust, and seemingly low-biased definition

(2015) Truls S. Ingebrigtsen et al.   RESPIRATORY MEDICINE

Mortality Rate in Type 2 Myocardial Infarction: Observations from an Unselected Hospital Cohort

(2014) Lotte Saaby et al.   AMERICAN JOURNAL OF MEDICINE

Cardiac risks associated with antibiotics: azithromycin and levofloxacin

(2014) Zhiqiang Kevin Lu et al.   Expert Opinion On Drug Safety

Use of self-controlled designs in pharmacoepidemiology

(2014) J. Hallas et al.   JOURNAL OF INTERNAL MEDICINE

Inflammatory Biomarkers and Exacerbations in Chronic Obstructive Pulmonary Disease

(2013) Mette Thomsen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cardiovascular Safety of Inhaled Long-Acting Bronchodilators in Individuals With Chronic Obstructive Pulmonary Disease

(2013) Andrea Gershon et al.   JAMA Internal Medicine

Chronic obstructive pulmonary disease and comorbidities

(2013) Marc Decramer et al.   Lancet Respiratory Medicine

Diagnosis of myocardial infarction following hospitalisation for exacerbation of COPD

(2012) David A. McAllister et al.   EUROPEAN RESPIRATORY JOURNAL

Exacerbation frequency and course of COPD

(2012) David Halpin et al.   International Journal of Chronic Obstructive Pulmonary Disease

Glucocorticoids and Cardiovascular Risk Factors

(2011) Erika A. Strohmayer et al.   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients

(2011) Riccardo Polosa et al.   Internal and Emergency Medicine

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT® Trial

(2011) David M. G. Halpin et al.   LUNG

Introduction to Danish (nationwide) registers on health and social issues: Structure, access, legislation, and archiving

(2011) Lau Caspar Thygesen et al.   SCANDINAVIAN JOURNAL OF PUBLIC HEALTH

Time course and pattern of COPD exacerbation onset

(2011) Shawn D Aaron et al.   THORAX

Mortality in COPD: Causes, Risk Factors, and Prevention

(2010) Cristine E. Berry et al.   COPD-Journal of Chronic Obstructive Pulmonary Disease

Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD

(2009) Gavin C. Donaldson et al.   CHEST

Clinical, functional and biochemical changes during recovery from COPD exacerbations

(2009) Angela Koutsokera et al.   RESPIRATORY MEDICINE